EPI Talks: Seen, Heard, and Cared For: Where Epilepsy Meets Identity | Building Affirming Spaces and Open Doors for all in the Epilepsy Clinic
Availability
No future session
Cost
$0.00
Credit Offered
No Credit Offered
Description
This EPI Talk explores the overlap of epilepsy care and gender-affirming care, highlighting the unique clinical, pharmacologic, and psychosocial considerations for transgender and gender-diverse individuals, including the interplay between gender-affirming hormone therapy and antiseizure medications. Drawing on her Epilepsy Currents article, "Inclusivity in Epilepsy Care: Navigating the Complex Nature of Seizure Disorders in People Undergoing Gender-Affirming Care," Sasha Alick-Lindstrom, MD, MPH, will share practical guidance and best practices to support inclusive, patient-centered care. Moderated by Shilpa Klocke, PharmD, BCPS. 

Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Describe the unique clinical, pharmacologic, and psychosocial considerations in the care of transgender and gender-diverse people with epilepsy.
  2. Understand the bidirectional interplay between gender-affirming hormone therapy and antiseizure medications, including effects on seizure control and hormone levels.
  3. Identify potential drug-hormone interactions and barriers to care in sample patient scenarios involving gender-affirming care.
  4. Analyze how stigma, discrimination, and systemic barriers affect access, adherence, and outcomes for LGBTQ+ patients with epilepsy.
  5. Evaluate current clinic practices, such as intake forms, language, and records, for inclusivity and gaps in affirming care.
  6. Develop a practical action plan to build inclusive, patient-centered epilepsy care environments that support equitable, high-quality care. 

Faculty:

Sasha Alick-Lindstrom, MD, MPH, FAAN, FACNS, FAES (she/her/hers)
Dr Sasha Alick-Lindstrom is an Associate Professor of Radiology, with a secondary appointment in Neurology, at UT Southwestern Medical Center in Dallas, Texas. She serves as Clinical Epilepsy Director of the Magnetoencephalography (MEG) Center of Excellence at the Peter O'Donnell Jr. Brain Institute.


She was born and raised in Puerto Rico. She pursued undergraduate studies at Cornell University in Ithaca, NY. She went on to earn her medical degree and complete an internship in internal medicine at UCC School of Medicine back home in Puerto Rico (UCCEM). She completed her residency in neurology at the University of Texas Health Science Center at Houston and then received advanced training in clinical neurophysiology and in epilepsy through separate fellowships at the University of Texas Health Science Center at San Antonio. Her clinical expertise centers on the evaluation and management of complex, drug-resistant epilepsy, with particular interests in advanced neurodiagnostic techniques, multimodal neuroimaging, epilepsy surgery, and neuromodulation. Her work integrates magnetoencephalography (MEG) and magnetic source imaging with comprehensive epilepsy evaluation to advance seizure localization and improve outcomes for patients with medically refractory epilepsy.

Dr Alick-Lindstrom is also actively engaged in national epilepsy leadership, clinical research, and education. Her professional interests extend to epilepsy in women throughout the lifespan, reproductive health, sexual and gender minorities living with epilepsy and neurologic conditions, neuropsychiatric comorbidities, and health equity, with a particular commitment to improving access to comprehensive epilepsy care. She has contributed to national professional initiatives, clinical guidelines, and educational programs through leadership and service within the American Academy of Neurology, American Epilepsy Society, and Epilepsy Foundation.

A dedicated clinician, educator, and advocate, Dr. Alick-Lindstrom is committed to advancing the field of epilepsy in an equitable manner, through innovative diagnostics, multidisciplinary care, and efforts to improve the lives of all individuals living with epilepsy.

Moderator:

Shilpa Klocke, PharmD, BCPS
Shilpa Klocke, PharmD, BS Pharm, BCPS has been a clinical pharmacy specialist for Kaiser Permanente in Colorado for more than 20 years where she has specialized in Neurology for than 17 years. In this role, she provides multiple sclerosis (MS) disease modifying therapy - related patient counseling, helped to create an MS population management safety monitoring program that utilizes a collaborative drug therapy management protocol and trains and provides mentorship to pharmacists throughout Kaiser Permanente who will become specialists in MS. She publishes research activities in MS and epilepsy, and precepts pharmacy students and residents. She is also employed as a part-time consultant on the Editorial Advisory Panel for Wolters Kluwer Health, Clinical Effectiveness Division and is an appointed member of the Health First Colorado (Colorado’s Medicaid Program) Drug Utilization Review board. In addition to MS, her clinical practice interests include epilepsy, headache, movement disorders, as well as, designing patient safety and medication cost-effectiveness processes. Dr. Klocke earned her Doctor of Pharmacy degree at the University of Wisconsin-Madison and completed PGY1 and PGY2 pharmacy practice residencies at Parkland Health & Hospital System in Dallas, Texas. 

 

For questions regarding this activity, please contact the American Epilepsy Society Education Department at education@aesnet.org or call (312) 883 3800. 
Powered By